B-cell Lymphoid Malignancies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-09-12
Clinical Trial Update: A First-in-Human Phase I Study of ESG206 in Subjects With B-cell Lymphoid Malignancies [Phase 1]
This update states that the first-in-human Phase I study of ESG206 in B-cell lymphoid malignancies has been withdrawn.